Polypharmacy and Hyperpolypharmacy in Older Individuals with Parkinson's Disease: A Systematic Review and Meta-Analysis

BACKGROUND AND AIM: Polypharmacy (concomitant use of 5–9 medicines) and hyperpolypharmacy (concomitant use of over 10 medicines) were observed to be more frequent in older adults (≥65 years) and associated with adverse outcomes. Their prevalence and risk in older patients with Parkinson's disea...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhagavathula, Akshaya Srikanth, Tesfaye, Wubshet, Vidyasagar, Kota, Fialova, Daniela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2022
Materias:
Clinical Section: Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9677850/
https://www.ncbi.nlm.nih.gov/pubmed/35026767
http://dx.doi.org/10.1159/000521214

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9677850/
https://www.ncbi.nlm.nih.gov/pubmed/35026767
http://dx.doi.org/10.1159/000521214

Ejemplares similares